Measuring fatigue in medically unwell and distressed patients

Current Opinion in Psychiatry

Volumn 14, Issue 6, 2001, Pages 585-590

  Prince, Martin I ^a   Jones, David E J ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; CARDIOVASCULAR DISEASE; CLINICAL EXAMINATION; DISEASE SEVERITY; ENDOCRINE DISEASE; FATIGUE; FUNCTIONAL ASSESSMENT; HUMAN; LIVER DISEASE; NEUROLOGIC DISEASE; PHENOTYPE; PREVALENCE; QUALITY OF LIFE; RESPIRATORY TRACT DISEASE; REVIEW; STRESS; SYMPTOMATOLOGY; WELLBEING;

EID: 0034778827     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001504-200111000-00017     Document Type: Review

References (62)

1. Inflammation and the mental state before an acute coronary event
2. Fatigue in chronic disease
3. The Functional Assessment of Cancer Therapy - Anemia (FACT-An) Scale: A new tool for the assessment of outcomes in cancer anemia and fatigue
4. Pretreatment symptoms and dosing regimen predict side-effects of interferon therapy for hepatitis C
5. A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer
6. Definition and measurement of fatigue
7. What do we call fatigue?
8. Fatigue: Current basis for practice
9. The MOS 36 item short form health survey (SF36)
10. An inventory for measuring depression
11. The hospital anxiety and depression scale
12. Comparing patient, parent, and staff descriptions of fatigue in pediatric ontology patients
13. Fatigue in patients with cancer - From an orphan topic to a global concern
14. NCCN practice guidelines for cancer-related fatigue
15. Impact of cancer-related fatigue on the lives of patients: New findings from the Fatigue Coalition
16. Nutritional aspects of cancer-related fatigue
17. Fatigue, depression and quality of life in cancer patients: How are they related?
18. Fatigue and its associated factors in ambulatory cancer patients: A preliminary study
19. Factors correlated with fatigue in disease-free breast cancer patients: Application of the Cancer Fatigue Scale
20. Fatigue in patients with prostate cancer receiving hormone therapy
21. Fatigue in women receiving adjuvant chemotherapy for breast cancer: Characteristics, course, and correlates
22. Is Fatigue a long-term side effect of breast cancer treatment?
23. Fatigue in advanced cancer - Meaning before measurement?
24. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system
25. Evaluating patient distress from cancer-related fatigue: An instrument development study
26. The Schwartz Cancer Fatigue Scale: Testing reliability and validity
27. Additional construct validity of the Schwartz Cancer Fatigue Scale
28. Development and validation of the cancer fatigue scale: A brief, three-dimensional, self-rating scale for assessment of fatigue in cancer patients
29. Measurement of fatigue in cancer patients: Development and validation of the Fatigue Symptom Inventory
30. Fatigue in women receiving adjuvant chemotherapy for breast cancer: Characteristics, course, and correlates
31. Measurement of fatigue in cancer patients: Further validation of the Fatigue Symptom Inventory
32. A multidimensional measure of fatigue for use with cancer patients
33. Reliability and validity of the Multidimensional Fatigue Inventory (MFI-20) and the Rhoten Fatigue Scale among rural cancer outpatients
34. Concurrent validity of the Beck Depression Inventory and the multidimensional fatigue inventory - 20 In assessing fatigue among cancer patients
35. Psychometric testing of fatigue instruments for use with cancer patients
36. Fatigue. Measures and relation to pain
37. How response shift may affect the measurement of change in fatigue
38. Revealing response shift in longitudinal research on fatigue - The use of the thentest approach
39. The rapid assessment of fatigue severity in cancer patients: Use of the Brief Fatigue Inventory
40. Fatigue in multiple sclerosis is associated with abnormal cortical activation to voluntary movement - EEG evidence
41. MRI and motor evoked potential findings in nondisabled multiple sclerosis with and without fatigue
42. Fatigue in multiple sclerosis
43. Validation of a fatigue impact score in primary biliary cirrhosis: Towards a standard for clinical and trial use
44. Impact of fatigue on quality of life in patients with primary biliary cirrhosis
45. The measurement of fatigue in patients with multiple sclerosis: A multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects
46. Clinical problems in non-fluctuating patients with Parkinson's disease: A community-based study
47. A review of health-related quality-of-life concepts and measures for Parkinson's disease
48. Fatigue in patients with Parkinson's disease
49. Fatigue and its impact on patients with myasthenia gravis
50. Fatigue in primary biliary cirrhosis
51. Morbidity of chronic hepatitis C as seen in a tertiary care medical center
52. Neuropsychiatric toxicity of antiviral treatment in chronic hepatitis C
53. Fatigue, mood, and hemodynamic patterns after myocardial infarction
54. Fatigue in women with myocardial infarction
55. Quality of life in older patients with systolic and diastolic heart failure
56. Development and testing of a new measure of health status for clinical trials in heart failure
57. Reproducibility and responsiveness of quality of life assessment and six minute walk test in elderly heart failure patients
58. Changes in dyspnea fatigue ratings as indicators of quality of life in the treatment of congestive heart failure
59. Measurement of fatigue in chronic obstructive pulmonary disease and in asthma
60. Quality of life in asthma. I. Internal consistency and validity of the SF-36 questionnaire
61. Long-term outcome of bilateral adrenalectomy in patients with Cushing's syndrome
62. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial